Do All Low Risk Microhematuria Patients Require Cystoscopy?
作者信息
Messing Edward M
机构信息
University of Rochester Medical Center, Rochester, NY, USA.
出版信息
Bladder Cancer. 2024 Oct 23;10(3):247-248. doi: 10.3233/BLC-249008. eCollection 2024.
Abstract
摘要
相似文献
1
Do All Low Risk Microhematuria Patients Require Cystoscopy?所有低风险镜下血尿患者都需要进行膀胱镜检查吗？
Bladder Cancer. 2024 Oct 23;10(3):247-248. doi: 10.3233/BLC-249008. eCollection 2024.
2
Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.初始检查阴性后的无症状镜下血尿患者行重复评估的诊断效果。
Urol Oncol. 2021 May;39(5):300.e1-300.e6. doi: 10.1016/j.urolonc.2020.11.032. Epub 2020 Dec 15.
3
A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.多中心前瞻性随机对照临床试验比较 Cxbladder 分诊与膀胱镜检查在镜下血尿患者中的应用：无症状镜下血尿危险的安全检测试验。
J Urol. 2024 Jul;212(1):41-51. doi: 10.1097/JU.0000000000003991. Epub 2024 May 3.
4
[The evaluation of cystoscopy in the screening of asymptomatic microhematuria].
Nihon Hinyokika Gakkai Zasshi. 1991 May;82(5):810-5. doi: 10.5980/jpnjurol1989.82.810.
5
A new diagnostic algorithm for the evaluation of microscopic hematuria.
Urology. 2001 May;57(5):889-94. doi: 10.1016/s0090-4295(00)01124-9.
6
Microhematuria: AUA/SUFU Guideline.微量血尿：AUA/SUFU 指南。
J Urol. 2020 Oct;204(4):778-786. doi: 10.1097/JU.0000000000001297. Epub 2020 Jul 23.
7
Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients.纳入尿基因组标志物 Cxbladder Detect 评估镜下血尿患者的预算影响。
Urol Pract. 2024 Jan;11(1):54-60. doi: 10.1097/UPJ.0000000000000489. Epub 2023 Nov 1.
8
Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.评估因镜下血尿就诊患者行膀胱镜检查和 CT 尿路造影对诊断泌尿系肿瘤的作用：系统评价和荟萃分析。
JAMA Netw Open. 2021 May 3;4(5):e218409. doi: 10.1001/jamanetworkopen.2021.8409.
9
The significance of asymptomatic microhematuria in women and its economic implications. A ten-year study.
Arch Intern Med. 1988 Dec;148(12):2629-32.
10
Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status.新诊断的膀胱癌：初始症状、微量血尿程度与肿瘤标志物状态的关系。
J Urol. 2002 Nov;168(5):1955-9. doi: 10.1016/S0022-5347(05)64271-1.
本文引用的文献
1
A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.多中心前瞻性随机对照临床试验比较 Cxbladder 分诊与膀胱镜检查在镜下血尿患者中的应用：无症状镜下血尿危险的安全检测试验。
J Urol. 2024 Jul;212(1):41-51. doi: 10.1097/JU.0000000000003991. Epub 2024 May 3.
2
Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients.纳入尿基因组标志物 Cxbladder Detect 评估镜下血尿患者的预算影响。
Urol Pract. 2024 Jan;11(1):54-60. doi: 10.1097/UPJ.0000000000000489. Epub 2023 Nov 1.
3
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.血尿的新美国泌尿外科学会指南风险分类评估。
J Urol. 2021 May;205(5):1387-1393. doi: 10.1097/JU.0000000000001550. Epub 2020 Dec 24.
4
Microhematuria: AUA/SUFU Guideline.微量血尿：AUA/SUFU 指南。
J Urol. 2020 Oct;204(4):778-786. doi: 10.1097/JU.0000000000001297. Epub 2020 Jul 23.
5
A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.一种将尿液样本中的表型（临床特征）和基因型（基因表达）生物标志物相结合的分类指数，用于筛选出血尿患者中尿路上皮癌可能性较低的患者。
BMC Urol. 2015 Mar 27;15:23. doi: 10.1186/s12894-015-0018-5.
Zotero 插件